KIDNEY TRANSPLANT REJECTION
Clinical trials for KIDNEY TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney transplant patients: safer Anti-Rejection drug tested
Disease control ENROLLING_BY_INVITATIONThis study tests a new drug called tegoprubart in people who have received a kidney transplant. The goal is to see if it is safe and works well over the long term compared to the standard drug tacrolimus. About 132 adults who completed a prior related study will take part. The ap…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Simple blood test could predict kidney transplant rejection before it happens
Diagnosis OngoingThis study is testing a new blood test that looks at your genes to predict if your body might reject a new kidney. About 550 kidney transplant patients will give blood samples before and after their transplant. The goal is to see if the test can spot early signs of rejection, so …
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Verici Dx • Aim: Diagnosis
Last updated May 05, 2026 11:55 UTC
-
15-Year Check-In: did the 'Smart' immune cells protect transplanted kidneys?
Knowledge-focused OngoingThis study follows 11 kidney transplant patients who previously received a personalized cell therapy (TX200-TR101) designed to prevent organ rejection. Researchers will monitor their health and kidney function for up to 15 years to see if the therapy remains safe and helps protec…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Sangamo Therapeutics • Aim: Knowledge-focused
Last updated May 04, 2026 16:20 UTC